GSK (LON:GSK) Receives “Hold” Rating from Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reaffirmed their hold rating on shares of GSK (LON:GSK – Get Rating) in a research note published on Wednesday, Marketbeat Ratings reports. They currently have a GBX 1,500 ($18.04) target price on the stock.

A number of other brokerages have also weighed in on GSK. Shore Capital restated a buy rating on shares of GSK in a research note on Friday, February 24th. UBS Group set a GBX 1,245 ($14.97) target price on shares of GSK in a research report on Wednesday, February 1st. Citigroup decreased their price target on shares of GSK from GBX 1,975 ($23.75) to GBX 1,550 ($18.64) and set a neutral rating for the company in a report on Friday, December 2nd. Berenberg Bank set a GBX 1,730 ($20.80) price objective on shares of GSK in a report on Friday, February 10th. Finally, JPMorgan Chase & Co. set a GBX 1,400 ($16.84) target price on GSK in a research report on Thursday, March 2nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of Hold and a consensus price target of GBX 1,551.11 ($18.65).

GSK Stock Performance

Shares of GSK stock opened at GBX 1,421.20 ($17.09) on Wednesday. GSK has a 12-month low of GBX 1,280.92 ($15.40) and a 12-month high of GBX 2,280.50 ($27.42). The business’s fifty day simple moving average is GBX 1,440.85 and its 200-day simple moving average is GBX 1,404.05. The company has a current ratio of 0.91, a quick ratio of 0.73 and a debt-to-equity ratio of 207.87. The company has a market cap of £58.13 billion, a PE ratio of 1,304.95, a PEG ratio of 1.14 and a beta of 0.27.

GSK Dividend Announcement

The firm also recently announced a dividend, which will be paid on Thursday, April 13th. Investors of record on Thursday, February 23rd will be given a dividend of GBX 13.75 ($0.17) per share. The ex-dividend date of this dividend is Thursday, February 23rd. This represents a yield of 0.97%. GSK’s dividend payout ratio is presently 5,596.33%.

Insider Buying and Selling at GSK

In related news, insider Urs Rohner acquired 798 shares of GSK stock in a transaction on Thursday, December 22nd. The stock was acquired at an average price of GBX 1,453 ($17.47) per share, for a total transaction of £11,594.94 ($13,942.93). In other news, insider Jonathan Symonds bought 2,100 shares of the firm’s stock in a transaction that occurred on Tuesday, December 20th. The stock was purchased at an average cost of GBX 1,417 ($17.04) per share, for a total transaction of £29,757 ($35,782.83). Also, insider Urs Rohner purchased 798 shares of the stock in a transaction that occurred on Thursday, December 22nd. The shares were purchased at an average cost of GBX 1,453 ($17.47) per share, for a total transaction of £11,594.94 ($13,942.93). Over the last three months, insiders have acquired 2,915 shares of company stock valued at $4,160,059. 0.72% of the stock is owned by insiders.

GSK Company Profile

(Get Rating)

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.